| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_119118a934be734b9f60b660b65e54bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29aca4bd10a4b566fb7375ecf51ba0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c9b6c4e3a9f7191865b6a151d40441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7546530720ec873b133428f864a43dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d63c8eb5370beb4f60a8a083fbe832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b9356785d1c45154f9b6d7d8cd7eec5 |
| publicationDate |
2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1336605-A1 |
| titleOfInvention |
Substituted benzene derivatives or salts thereof |
| abstract |
There are provided compounds having annanticoagulant action on the basis of inhibition ofnactivated blood coagulation factor X and being useful asnanticoagulants or preventive/therapeutic agents forndiseases induced by thrombosis or embolism. Effectiveningredients are the compounds such as 4'-bromo-2'-[(5-chloro-2-pyridyl)carbamoyl)-6-β-D-galactopyranosyloxy-1-isopropylpiperidine-4-carboxanilide,n2'-(2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-4'-bromo-6'-[(5-chloro-2-pyridyl)carbamoyl]-1-isopropylpiperidine-4-carboxanilide,netc. or salts thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008135524-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008135524-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102014108210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022214485-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11678659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4070658-A1 |
| priorityDate |
2000-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |